PET-CT can inform decision to omit bleomycin in Hodgkin lymphoma treatment to reduce toxicity

Hodgkin lymphoma in patients with negative findings on an interim PET scan led to a lower incidence of pulmonary toxic effects without significantly lowering treatment efficacy; however, the results did fall just short of the specified noninferiority margin. Read more.